Evidence map›Paper›PMID 37686257›Full record

ArticleInternational journal of molecular sciences2023

Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes.

Laia Llucià-Carol, Elena Muiño, Natalia Cullell, Jara Cárcel-Márquez, Miquel Lledós, Cristina Gallego-Fabrega, Jesús Martin-Campos, Joan Martí-Fàbregas, Ana Aguilera-Simón, Anna M Planas and 23 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Genetics in Ischemic Stroke: Current Perspectives and Future Directions.Journal of cardiovascular development and disease · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 17 institutions in 4 countries.

Laia Llucià-CarolStroke Pharmacogenomics and Genetics, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0000-0002-7732-0665
Elena MuiñoStroke Pharmacogenomics and Genetics, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
Natalia CullellStroke Pharmacogenomics and Genetics, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
Jara Cárcel-MárquezStroke Pharmacogenomics and Genetics, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0000-0002-6949-0699
Miquel LledósStroke Pharmacogenomics and Genetics, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0000-0001-8832-789X
Cristina Gallego-FabregaStroke Pharmacogenomics and Genetics, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0000-0003-3229-5512
Jesús Martin-CamposStroke Pharmacogenomics and Genetics, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0000-0003-0414-037X
Joan Martí-FàbregasDepartment of Neurology, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.ORCID 0000-0001-9229-8649
Ana Aguilera-SimónDepartment of Neurology, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.ORCID 0000-0003-1428-8212
Anna M PlanasInstitute for Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Spain.
Marta L DeDiegoDepartment of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Campus Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0000-0002-7888-7372
Alicia de Felipe MimbreraInstituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón Y Cajal, 28034 Madrid, Spain.
Jaime MasjuanInstituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón Y Cajal, 28034 Madrid, Spain.ORCID 0000-0003-1329-0943
Sebastián García-MadronaInstituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón Y Cajal, 28034 Madrid, Spain.
Tomás SeguraDepartment of Neurology, University Hospital of Albacete, 02006 Albacete, Spain.ORCID 0000-0003-3625-0987
Esther González-VillarDepartment of Neurology, University Hospital of Albacete, 02006 Albacete, Spain.
Gemma Serrano-HerasDepartment of Neurology, University Hospital of Albacete, 02006 Albacete, Spain.
Ana Domínguez MayoralInstitute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla, 410113 Seville, Spain.
Paloma Menéndez-ValladaresInstitute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla, 410113 Seville, Spain.
Joan MontanerInstitute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla, 410113 Seville, Spain.
Isabelle MigeotteFonds de la Recherche Scientifique (FNRS), 1000 Brussels, Belgium.
Souad RahmouniFonds de la Recherche Scientifique (FNRS), 1000 Brussels, Belgium.
Gilles DarcisFonds de la Recherche Scientifique (FNRS), 1000 Brussels, Belgium.ORCID 0000-0001-8192-1351
David BernardoMucosal Immunology Lab, Unidad de Excelencia del Instituto de Biomedicina y Genética Molecular (IBGM), Universidad de Valladolid-CSIC, 47005 Valladolid, Spain.
Silvia RojoDepartment of Microbiology, Hospital Clínico Universitario de Valladolid, Gerencia Regional de Salud de Castilla y León (SACYL), 47003 Valladolid, Spain.
Eva C SchulteInstitute of Virology, Technical University Munich/Helmholtz Zentrum München, 81377 Munich, Germany.ORCID 0000-0003-3105-5672
Ulrike ProtzerInstitute of Virology, Technical University Munich/Helmholtz Zentrum München, 81377 Munich, Germany.ORCID 0000-0002-9421-1911
Lisa FrickeDepartment of Internal Medicine II, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.ORCID 0000-0002-9268-0546
Christof WinterInstitute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technische Universität München (TUM), 81675 Munich, Germany.ORCID 0000-0002-0253-9056
Mari E K NiemiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00014 Helsinki, Finland.
Mattia CordioliInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00014 Helsinki, Finland.
Pilar DelgadoDepartment of Neurology, Hospital Universitari de la Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-1628-4488
Israel Fernández-CadenasStroke Pharmacogenomics and Genetics, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
Hospital de Sant Pau · ESHospital General Universitario de Albacete · ESHospital Universitario Virgen Macarena · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESUniversitat Autònoma de Barcelona · ESUniversity of Helsinki · FICentro Nacional de Biotecnología · ESConsejo Superior de Investigaciones Científicas · ESFund for Scientific Research · BEHelmholtz Zentrum München · DEHospital Clínico Universitario de Valladolid · ESTechnical University of Munich · DETUM Klinikum · DEUniversidad de Valladolid · ESUniversité Libre de Bruxelles · BEUniversity of Bonn · DEUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to analyse whether patients with ischaemic stroke (IS) occurring within eight days after the onset of COVID-19 (IS-COV) are associated with a specific aetiology of IS. We used SUPERGNOVA to identify genome regions that correlate between the IS-COV cohort (73 IS-COV cases vs. 701 population controls) and different aetiological subtypes. Polygenic risk scores (PRSs) for each subtype were generated and tested in the IS-COV cohort using PRSice-2 and PLINK to find genetic associations. Both analyses used the IS-COV cohort and GWAS from MEGASTROKE (67,162 stroke patients vs. 454,450 population controls), GIGASTROKE (110,182 vs. 1,503,898), and the NINDS Stroke Genetics Network (16,851 vs. 32,473). Three genomic regions were associated (

Indexed as

AtherosclerosisBrain IschemiaCOVID-19Embolic StrokeIschemic StrokeStrokeArteriesHumansCOVID-19GWASischaemic strokelocal genetic correlationPRS

Identifiers

PMID37686257
PMCPMC10487930
OpenAlexW4386284685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.